{"organizations": [], "uuid": "84d64d926ccfc245b2c073cb604c0f59d0bbb2bc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-highmark-inc-signs-outcomes-based/brief-highmark-inc-signs-outcomes-based-agreement-with-astrazeneca-for-symbicort-idUSFWN1RU0TI", "country": "US", "domain_rank": 408, "title": "BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-17T15:07:00.000+03:00", "replies_count": 0, "uuid": "84d64d926ccfc245b2c073cb604c0f59d0bbb2bc"}, "author": "", "url": "https://www.reuters.com/article/brief-highmark-inc-signs-outcomes-based/brief-highmark-inc-signs-outcomes-based-agreement-with-astrazeneca-for-symbicort-idUSFWN1RU0TI", "ord_in_thread": 0, "title": "BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-highmark inc", "sentiment": "negative"}, {"name": "astrazeneca", "sentiment": "negative"}, {"name": "astrazeneca plc", "sentiment": "none"}, {"name": "symbicort", "sentiment": "none"}, {"name": "highmark inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "symbicort reuters staff", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 17, 2018 / 12:08 PM / Updated 10 minutes ago BRIEF-Highmark Inc Signs Outcomes-Based Agreement With Astrazeneca For Symbicort Reuters Staff 1 Min Read \nApril 17 (Reuters) - AstraZeneca PLC: \n* HIGHMARK INC. SIGNS OUTCOMES-BASED AGREEMENT WITH ASTRAZENECA FOR SYMBICORT Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-17T15:07:00.000+03:00", "crawled": "2018-04-17T15:21:53.020+03:00", "highlightTitle": ""}